SEMLER SCIENTIFIC, INC.

(SMLR)
  Report
Delayed Nasdaq  -  05/19 04:00:00 pm EDT
28.57 USD   +0.18%
05/06SEMLER SCIENTIFIC, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
05/03B. Riley Lowers Semler Scientific's Price Target to $60 from $70 After Lower-than-Expected Q1 Results, Keeps Buy Rating
MT
05/02TRANSCRIPT : Semler Scientific, Inc., Q1 2022 Earnings Call, May 02, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q3 Revenue $13.9M, vs. Street Est of $15.1M

11/01/2021 | 03:04pm EDT


© MT Newswires 2021
All news about SEMLER SCIENTIFIC, INC.
05/06SEMLER SCIENTIFIC, INC. Management's Discussion and Analysis of Financial Condition an..
AQ
05/03B. Riley Lowers Semler Scientific's Price Target to $60 from $70 After Lower-than-Expec..
MT
05/02TRANSCRIPT : Semler Scientific, Inc., Q1 2022 Earnings Call, May 02, 2022
CI
05/02Semler Scientific, Inc. Provides Earnings Guidance for the Second Quarter and Full Year..
CI
05/02Semler Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, ..
CI
05/02Semler Reports First Quarter 2022 Financial Results
PR
05/02Earnings Flash (SMLR) SEMLER SCIENTIFIC Reports Q1 Revenue $14M, vs. Street Est of $14...
MT
04/19Semler to Report First Quarter 2022 Financial Results and Host Conference Call on May 2..
PR
04/07Semler to Participate in the 21st Annual Needham Virtual Healthcare Conference
PR
03/20SEMLER SCIENTIFIC, INC.(NASDAQCM : SMLR) added to S&P Global BMI Index
CI
More news
Analyst Recommendations on SEMLER SCIENTIFIC, INC.
More recommendations
Financials (USD)
Sales 2022 58,5 M - -
Net income 2022 10,5 M - -
Net cash 2022 46,5 M - -
P/E ratio 2022 22,3x
Yield 2022 -
Capitalization 194 M 194 M -
EV / Sales 2022 2,52x
EV / Sales 2023 1,81x
Nbr of Employees 124
Free-Float 73,2%
Chart SEMLER SCIENTIFIC, INC.
Duration : Period :
Semler Scientific, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 28,57 $
Average target price 62,50 $
Spread / Average Target 119%
EPS Revisions
Managers and Directors
Douglas R. Murphy-Chutorian Chief Executive Officer & Director
Andrew B. Weinstein Senior Vice President-Finance & Accounting
Robert G. McRae Chief Technical Officer
Wayne T. Pan Independent Director
Arthur N. Leibowitz Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SEMLER SCIENTIFIC, INC.-68.83%194
GETINGE AB-27.08%7 842
MASIMO CORPORATION-53.26%7 596
NOVOCURE LIMITED-1.37%7 293
SHOCKWAVE MEDICAL, INC.-10.16%5 810
PENUMBRA, INC.-50.46%5 445